Skip to main content

Schizophrenia News (Page 2)

Related terms: Catatonic Schizophrenia, Disorganized Schizophrenia, Paranoid Schizophrenia, Residual Schizophrenia, Schizophrenia, catatonic, Schizophrenia, disorganized, Schizophrenia, paranoid, Schizophrenia, residual, Schizophrenia, undifferentiated, Undifferentiated Schizophrenia

Antipsychotics at Doses >75 mg a Day Linked to Risk for Tardive Dyskinesia

FRIDAY, Jan. 17, 2025 – Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to a study recently published in the Journal of Clinical...

Pandemic Led to Rapid Adoption of Telemental Health for Those With Schizophrenia

FRIDAY, Jan. 17, 2025 – For Medicaid beneficiaries with schizophrenia, delivery of mental health care through telehealth (telemental health care) diffused rapidly after onset of the COVID-19...

Guidance Issued for Use of Metformin to Prevent Antipsychotic-Induced Weight Gain

MONDAY, Dec. 30, 2024 – In a guideline published online Dec. 9 in Schizophrenia Bulletin, recommendations are presented for the use of metformin to prevent antipsychotic-induced weight gain (AIWG)....

The Number of Homeless People in the U.S. Has Increased

MONDAY Dec. 30, 2024 – The number of homeless individuals in the U.S. increased by 18% between January 2023 and January 2024, according to the U.S. Department of Housing and Urban Development (HUD)....

Need Some 'Alone Time'? It's Vital to Mental Health for Many

TUESDAY, Dec. 3, 2024 – The hectic holidays play havoc on people’s nerves, not the least because they aren’t able to have any time to themselves. Nearly half (46%) of Americans say they don’t get the...

Risk for Schizophrenia Increased With ED Visits Involving Hallucinogen Use

THURSDAY, Nov. 21, 2024 – In individuals without a history of psychosis, the risk for developing a schizophrenia spectrum disorder (SSD) is increased for individuals with an emergency department...

Transcranial Direct Current Stimulation Safe, Effective for Tardive Dyskinesia

MONDAY, Nov. 18, 2024 – Transcranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically...

FDA Approves Cobenfy for Adults With Schizophrenia

THURSDAY, Nov. 14, 2024 – The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in...

Psychedelics Like Psilocybin, MDMA Tied to Higher Odds for Schizophrenia

WEDNESDAY, Nov. 13, 2024 – People are at higher risk of schizophrenia if they indulge in psychedelic drugs, a new study warns. Patients who land in the ER following hallucinogen use have a 21-fold...

Childhood Attention Issues Show Links to Later Risk for Psychosis, Schizophrenia

TUESDAY, Oct. 29, 2024 – Most kids with attention issues won't go on to develop serious psychiatric conditions like psychosis or schizophrenia. However, a new study finds poor attention spans in...

Risk for Sudden Cardiac Death Elevated for Patients With Psychiatric Disorders

WEDNESDAY, Oct. 23, 2024 – Patients with psychiatric disorders have an increased rate of sudden cardiac death (SCD), according to a study published online Oct. 22 in Heart. Jasmin Mujkanovic, from...

High Rate of Comorbid Mental Health Disorders Seen in Schizophrenia

TUESDAY, Oct. 8, 2024 – Adults with schizophrenia spectrum disorders have high rates of comorbid mental health and substance use disorders, according to a study published online Sept. 23 in...

FDA Approves Cobenfy (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults

PRINCETON, N.J.--(BUSINESS WIRE)--26 September 2024-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and...

FDA Approves Cobenfy, a New Kind of Drug for Schizophrenia

FRIDAY, Sept. 27, 2024 – The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration. Cobenfy...

Most People With Schizophrenia Aren't Getting Treated

WEDNESDAY, Sept. 25, 2024 – Only 1 in every 4 U.S. adults struggling with schizophrenia receive "minimally adequate treatment," new data shows. Many of these patients also struggle with other mental...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Schizoaffective Disorder

Related drug support groups

Seroquel, Abilify, Latuda, quetiapine, Vraylar, olanzapine, risperidone, Zyprexa, Risperdal, view more... aripiprazole, Rexulti, Seroquel XR, Geodon, Invega, lurasidone, Invega Sustenna